Randomised double blind placebo control study of adjuvant treatment with the metalloproteinase inhibitor, Marimastat in patients with inoperable colorectal hepatic metastases: significant survival advantage in patients with musculoskeletal side-effe (Q44393350)
Jump to navigation
Jump to search
scientific article published in January 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomised double blind placebo control study of adjuvant treatment with the metalloproteinase inhibitor, Marimastat in patients with inoperable colorectal hepatic metastases: significant survival advantage in patients with musculoskeletal side-effe |
scientific article published in January 2003 |
Statements
Randomised double blind placebo control study of adjuvant treatment with the metalloproteinase inhibitor, Marimastat in patients with inoperable colorectal hepatic metastases: significant survival advantage in patients with musculoskeletal side-effects (English)
Julie King
Jing Zhao
Phillip Clingan
1 January 2003